life sciences news bucket

  1. Biotech Company Uses Microbial Fermentation Process In Carbon Recycling Technology 4/17/2024

    “We want it so every child in the world can pick up a crayon and color the sky and have that crayon that they pick is blue, right, and today that’s not the reality for every kid around the world,” Zara Summers, Chief Science Officer at LanzaTech, a Biotech Company, vividly articulates the company’s goal to reduce fossil fuel consumption and instead, recycle carbon, that is already above ground to create necessities.

  2. AES Clean Technology Sets New Standards For Cleanliness And Efficiency In cleanrooms with The Launch Of Its CleanLock Module 4/16/2024

    AES Clean Technology, a leading provider of high-performance cleanroom facilities, has launched its CleanLock Module™ today. This revolutionary airlock solution enhances cleanliness, speed, and efficiency in cleanroom project execution.

  3. Imugene And Kincell Bio Announce Strategic Manufacturing And Process Development Partnership 4/16/2024

    Imugene, Ltd. (“Imugene”)(ASX: IMU) and Kincell Bio, LLC (“Kincell”), announce a strategic manufacturing and process development partnership, which includes the sale of Imugene’s North Carolina Current Good Manufacturing Practice (CGMP) manufacturing facility and the transfer of process and analytical development activities to Kincell.

  4. John Witkowski Appointed President & CEO Of Solesis 4/9/2024

    Solesis, a leader in the custom design, development, and manufacturing of textile- and polymer-based healthcare solutions for the medical device and biopharmaceutical industries, is pleased to announce that John Witkowski has been appointed as the new President & CEO, effective immediately. In this role, Witkowski is responsible for developing the strategic priorities for Solesis and executing world-class business operations to support customers and drive long-term, sustainable growth.

  5. Honeywell Announces Upcoming Webinar and Conference Schedule 3/19/2024

    Visit us at Booth 17 to learn more about our unified manufacturing operations platform and how it accelerates innovation and increases efficiency, quality, and compliance.

  6. Pluri Selected As CDMO By Remedy Cell For Cell-Derived Cell-Free Drug Manufacturing 3/14/2024

    Pluri Inc. (Nasdaq:PLUR) (TASE:PLUR) ("Pluri" or "the Company"), a leading biotechnology company that transforms cells into solutions, today announced that its CDMO division (PluriCDMO™) has signed a manufacturing agreement with Remedy Cell Ltd, an innovative, biopharmaceutical company developing stem cell-derived, cell-free therapeutics for complex fibrotic conditions.

  7. List Biotherapeutics And Sacco System Announce Lead Share Agreement 3/13/2024

    List Biotherapeutics, Inc. (List Bio) and Sacco System Australia Pty Ltd (Sacco) today announced a lead share agreement to introduce and mutually recommend each other’s microbial development and manufacturing services to prospective customers if one party discovers a project that is better suited to the other party’s capability or capacity. No intellectual property will be exchanged between the companies.

  8. FUJIFILM Diosynth Biotechnologies Announces Renewable Energy PPA With Better Energy For Denmark Manufacturing Site 2/29/2024

    FUJIFILM Diosynth Biotechnologies, a world-leading CDMO for biologics, vaccines, advanced therapies and oncolytic viruses, has entered into a ten-year Power Purchase Agreement (PPA) to offtake 40 GWh of renewable energy annually with Better Energy, an integrated renewable energy company in Northern Europe.

  9. CDMO Resilience Announces Modular Facility Design Investment At RTP Location 2/29/2024

    National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company dedicated to broadening access to complex medicines, announced the expansion of the company’s clinical and commercial drug product manufacturing capabilities across its network, which includes a biomanufacturing plant in Durham the company acquired in 2021. 

  10. Simtra BioPharma Solutions Announces $250+M Investment To Expand Sterile Fill/Finish Manufacturing Site In Bloomington, Indiana 2/28/2024

    Simtra BioPharma Solutions (Simtra), a premier injectable contract development and manufacturing organization (CDMO), today announced a $250+ million expansion of its sterile fill/finish manufacturing campus in Bloomington, Indiana.